Category Archives: Pfizer and the country’s Anti-trust problem

Pfizer and the country’s Anti-trust problem

Pfizer, according to a Washington Post article this week, ignored evidence a drug it makes and markets, Enbrel, had promise against a terrible scourge, Alzheimer’s. The story, by Christopher Rowland, has a dramatic lede; “A team of researchers inside Pfizer … Continue reading

Posted in Pfizer and the country's Anti-trust problem, Uncategorized | Leave a comment